American Journal of Gastroenterology

FIGURE 3

FROM:

ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease

Alberto Rubio-Tapia, Ivor D Hill, Ciarán P Kelly, Audrey H Calderwood and Joseph A Murray

BACK TO ARTICLE

Figure 3.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

An approach to monitoring celiac disease (CD) (adapted from Rubio-Tapia A. Seguimiento Médico del Paciente Celiaco. En Rodrigo L (ed.) Enfermedad Celiaca. Barcelona, España. OmniaScience, 2013, in press). (1) Tissue transglutaminase and deamidated gliadin peptide can be used for monitoring CD. (2) Other tests may include complete blood count, alanine aminotransferase, vitamins (A, D, E, B12), copper, zinc, carotene, folic acid, ferritin, and iron. (3) Blood tests at follow-up should be individualized to verify correction of laboratory tests that were abnormal at baseline. (4) The role of biopsy for monitoring CD is discussed in detail in the text. DXA, dual-energy X-ray absorptiometry; GFD, gluten-free diet.

BACK TO ARTICLE